CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

TECHBIO-TECHNE Corp

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $72.47 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$11.35B
RECENT INSIDER TRADES
  • 2026-09-30 · HIGGINS JOHN L (Director) · OTHER
  • 2026-09-24 · BAUMGARTNER ROBERT V (Director) · OTHER
  • 2026-08-18 · Herr Amy E. (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders646
Shares held212,362,300
Value$14.50B
Percent of shares outstanding135.64%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-04-08 · Hon. April McClain Delaney · SELL · $1,001 - $15,000
  • 2026-03-26 · Hon. April McClain Delaney · SELL · $1,001 - $15,000
  • 2026-02-24 · Hon. April McClain Delaney · SELL · $1,001 - $15,000
  • 2026-01-28 · Hon. April McClain Delaney · SELL · $1,001 - $15,000
  • 2025-12-05 · Hon. April McClain Delaney · BUY · $1,001 - $15,000
RECENT NEWS
  • Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development
  • Is Bio-Techne Stock Outperforming the Nasdaq?
  • Bio-Techne shareholders approve Merck KGaA acquisition
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS